A prototype AI, created by Scottish medical imaging company Data Lab and The University of Glasgow, has been programmed to automatically identify and measure mesothelioma tumor volume in CT scans which are then used by trained AI to assess a patient’s response to treatment.

Automating these calculations with accuracy and speed will allow more data to emerge and ultimately develop new clinical trials for more individualized care.

The remarkable healthcare innovation has the potential to revolutionize care with more targeted treatment and could also be applied to other cancers in the future.